ストックスクリーナーアプリを入手
25.99
1.92%
0.49
前日終値:
$25.50
開ける：
$25.5
24時間の取引高:
1.07M
Relative Volume:
2.37
時価総額：
$753.93M
収益：
$219.79M
当期純損益:
$-57.47M
株価収益率:
-12.09
EPS:
-2.15
ネットキャッシュフロー:
$-19.25M
1週間 パフォーマンス:
+8.47%
1か月 パフォーマンス:
+14.39%
6か月 パフォーマンス:
+34.32%
1年 パフォーマンス:
-21.60%
1日の値動き範囲:
$25.29
$26.97
1週間の範囲:
$23.31
$26.97
52週間の値動き範囲:
$14.59
$35.84
Castle Biosciences Inc Stock (CSTL) Company Profile
名前
Castle Biosciences Inc
セクター
電話
866-788-9007
住所
505 S FRIENDSWOOD DRIVE, FRIENDSWOOD, TX
CSTL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CSTL
Castle Biosciences Inc
|
25.99 | 739.71M | 219.79M | -57.47M | -19.25M | -2.15 |
|
TMO
Thermo Fisher Scientific Inc
|
564.88 | 213.17B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
214.06 | 152.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
722.94 | 50.36B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
144.69 | 41.49B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
213.88 | 36.86B | 15.90B | 1.28B | 2.21B | 7.2842 |
Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-12-14 | 開始されました | Guggenheim | Buy |
| 2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
| 2022-01-07 | 開始されました | Stephens | Overweight |
| 2021-04-30 | 開始されました | Lake Street | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2019-12-27 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-08-19 | 開始されました | BTIG Research | Buy |
| 2019-08-19 | 開始されました | Canaccord Genuity | Buy |
| 2019-08-19 | 開始されました | Robert W. Baird | Outperform |
| 2019-08-19 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Castle Biosciences Inc (CSTL) 最新ニュース
Castle Biosciences Inc (CSTL) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo! Finance Singapore
Castle Biosciences (CSTL) Reports Strong Q3 Revenue Surge - GuruFocus
Earnings call transcript: Castle Biosciences Q3 2025 beats revenue forecast - Investing.com
Castle Biosciences revenue hits 83 million in Q3 amid 36 percent test surge - Traders Union
Castle Biosciences (CSTL) Boosts 2025 Revenue Guidance - GuruFocus
Castle Biosciences Ups Guidance As New Tests Drive Growth - Finimize
Castle Biosciences Inc (CSTL) Q3 2025 Earnings: Revenue Surpasses Estimates at $83M, EPS Loss Narrows to $0.02 - GuruFocus
Castle Biosciences Reports Third Quarter 2025 Results - Bluefield Daily Telegraph
Castle Biosciences Launches AdvanceAD-Tx™ to Help Guide - GlobeNewswire
Chart based analysis of Castle Biosciences Inc. trendsJuly 2025 Macro Moves & Community Supported Trade Ideas - newser.com
Pattern recognition hints at Castle Biosciences Inc. upsideRate Cut & Fast Entry High Yield Tips - newser.com
Full technical analysis of Castle Biosciences Inc. stockTreasury Yields & AI Powered Trade Plan Recommendations - newser.com
Will Castle Biosciences Inc. stock remain a Wall Street favoriteLong Setup & Entry Point Confirmation Signals - newser.com
Is Castle Biosciences Inc. stock a dividend growth opportunity2025 Big Picture & Entry Point Confirmation Signals - newser.com
Why hedge funds are buying Castle Biosciences Inc. stockBond Market & Capital Efficiency Focused Ideas - newser.com
Is Castle Biosciences Inc. stock attractive for income investorsInsider Buying & Comprehensive Market Scan Insights - newser.com
Quantitative breakdown of Castle Biosciences Inc. recent moveMarket Risk Report & Real-Time Market Trend Scan - newser.com
Statistical indicators supporting Castle Biosciences Inc.’s strengthJuly 2025 Short Interest & Entry Point Confirmation Alerts - newser.com
Y Intercept Hong Kong Ltd Buys Shares of 78,938 Castle Biosciences, Inc. $CSTL - MarketBeat
When is the best time to exit Castle Biosciences Inc.Weekly Trend Recap & High Accuracy Swing Trade Signals - newser.com
Evaluating Castle Biosciences Inc. with trendline analysisQuarterly Profit Report & Daily Profit Focused Screening - newser.com
Risk adjusted return profile for Castle Biosciences Inc. analyzed2025 Analyst Calls & Momentum Based Trading Signals - newser.com
Castle Biosciences (NASDAQ:CSTL) Given Sell (D-) Rating at Weiss Ratings - MarketBeat
What technical signals suggest for Castle Biosciences Inc. stockWeekly Profit Report & Technical Analysis for Trade Confirmation - newser.com
Castle Biosciences Inc (CSTL) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance
Castle Biosciences Inc (CSTL) Q3 2025 Earnings Report Preview: W - GuruFocus
Zacks.com featured highlights include RadNet, Mission Produce, Castle Biosciences and FreightCar America - sharewise.com
Earnings visualization tools for Castle Biosciences Inc.Quarterly Profit Summary & Short-Term Trading Alerts - newser.com
Can Castle Biosciences Inc. stock deliver consistent earnings growthJuly 2025 Retail & Free Reliable Trade Execution Plans - newser.com
Castle Biosciences Inc. recovery potential after sell offRisk Management & Real-Time Market Trend Scan - newser.com
Castle Biosciences Inc (CSTL) 財務データ
収益
当期純利益
現金流量
EPS
1.64%
1.15%
大文字化:
|
ボリューム (24 時間):